The new AI test, built by a team from the US, UK and Switzerland, shows which men would most likely benefit from abiraterone.

Dr. M. Blair Marshall, thoracic oncology surgeon with the Jellison Cancer Institute, was the first physician on the Gulf Coast to use the technology ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...

Trodelvy, in combination with Keytruda, significantly lowers the risk of progression in triple-negative breast cancer by 35%, ...

Pfizer and Arvinas' experimental treatment significantly extends progression-free survival in breast cancer patients with ...

A new study has revealed that the drug called pembrolizumab, sold under the brand name Keytruda, not only kept head and neck ...

A “breakthrough” new three-drug combination offers hope for women battling an aggressive form of breast cancer, potentially ...

"Getting out the shower, I felt a tiny spot as I moisturized by body. I trusted my gut and went to get it checked out. I never could have imagined what happened next." ...

Palliative nurse's notes, Aug. 2, 2019: "Participated in Hospice meeting with patient. Seth (spouse), mother, father, bedside RN. Andrea from Hospice was on speakerphone. Discussed philosophy of ...

Children who have bone cancer face extremely longer waits for a diagnosis than those with other types of the disease, a new ...

Dr Amy Proffitt is among palliative care doctors who have concerns about the erosion of end of life care if the bill passes.

According to the health department statement, the elderly patient who was fully vaccinated was on post operative chemotherapy ...